TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
90
|
69
|
107 |
| Financial expenses |
5
|
10
|
38 |
| Earnings before taxes |
29
|
-10
|
8 |
| EBITDA |
33
|
-1
|
46 |
| Total assets |
1,299
|
1,281
|
1,276 |
| Current assets |
66
|
67
|
99 |
| Current liabilities |
14
|
23
|
33 |
| Equity capital |
1,280
|
1,253
|
1,234 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
98.5%
|
97.8%
|
96.7% |
| Turnover per employee |
90
|
69
|
107 |
| Profit as a percentage of turnover |
32.2%
|
-14.5%
|
7.5% |
| Return on assets (ROA) |
2.6%
|
0%
|
3.6% |
| Current ratio |
471.4%
|
291.3%
|
300% |
| Return on equity (ROE) |
2.3%
|
-0.8%
|
0.6% |
| Change turnover |
19
|
-42
|
41 |
| Change turnover % |
27%
|
-38%
|
62% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.